Fundraising FoxAdvanced Tear Diagnostics
Birmingham, US · Delaware LLC
Find your way into Advanced Tear Diagnostics
Each arrow is one introduction. Sign up to fill in the first one.
165 people can intro you to Andrew
Ask Ian Penny to introduce you to Andrew Penman
You →Ian · together at University of Kent →Andrew
14 people can intro you to Marcus
Ask Jamie Chen to introduce you to Marcus Smith
You →Jamie · together at Troy University →Marcus
Sign up to find every way you can get introduced to Advanced Tear Diagnostics
- Your email: who you already know at Advanced Tear Diagnostics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Advanced Tear Diagnostics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
AP
Andrew PenmanChief Technology Officer2016–2017Andrew Penman held executive roles at Angiotech where he led the Vascular Wrap Project Team through regulatory pathways and managed preclinical groups on local drug delivery projects, and at Southern Research where he co-founded the Alabama Medical Device Forum and contributed to medical device development with expertise in regulatory affairs, drug delivery, and bioanalysis.
JB
Jeffrey BusbyExecutive
CV
Catalina ValenciaExecutive
GW
Gene WahnefriedExecutive
MS
Marcus SmithCEOMarcus Smith brings over 20 years of healthcare experience across clinical operations, strategic planning, and business development, with particular expertise in ophthalmology and optometry. He is an executive officer and director at Advanced Tear Diagnostics.
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 2 rounds · 2012–2014
▶$385KraisedOct 2016 · 10 investors · BiotechnologyRule 506(b)
▶$385KraisedOct 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew PenmanExecutive Officer
- Jeffrey BusbyExecutive Officer
- Catalina ValenciaExecutive Officer
- Gene WahnefriedExecutive Officer
- Pierce YoungbarExecutive Officer
- Marcus SmithExecutive Officer, Director
- Offering amount
- $385K
- Amount sold
- $385K
- Minimum investment
- $15K
- First sale
- Mar 2012
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedSep 2016 · 18 investors · BiotechnologyRule 506(b)
▶$1.4MraisedSep 2016 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey BusbyExecutive Officer
- Marcus SmithExecutive Officer, Director
- Pierce YoungbarExecutive Officer
- Andrew PenmanExecutive Officer
- Catalina ValenciaExecutive Officer
- Gene WahnefriedExecutive Officer
- Offering amount
- $7M
- Amount sold
- $1.4M
- Minimum investment
- $25K
- First sale
- Jan 2014
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Advanced Tear Diagnostics raised?
- Advanced Tear Diagnostics has disclosed $1.8M raised across 2 rounds.
- Where is Advanced Tear Diagnostics headquartered?
- Advanced Tear Diagnostics is headquartered in Birmingham, US.